1. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features
- Author
-
Cheng-Hsiang Hsiao, Yi-Chun Chen, Chia-Yu Chu, Wen-Hung Chung, Jheng-Wei Lin, Chia-Ying Chang, and Yung-Tsu Cho
- Subjects
Antigens, Differentiation, T-Lymphocyte ,Male ,Pathology ,medicine.medical_specialty ,Dermatology ,Severity of Illness Index ,Fas ligand ,Cohort Studies ,Diagnosis, Differential ,Young Adult ,medicine ,Humans ,Granulysin ,Aged ,Retrospective Studies ,Aged, 80 and over ,Skin Diseases, Vesiculobullous ,Perforin ,business.industry ,Biopsy, Needle ,FOXP3 ,Forkhead Transcription Factors ,Middle Aged ,Eosinophil ,Prognosis ,medicine.disease ,Immunohistochemistry ,Toxic epidermal necrolysis ,Drug eruption ,Granzyme B ,stomatognathic diseases ,medicine.anatomical_structure ,Stevens-Johnson Syndrome ,Female ,Drug Eruptions ,business ,Biomarkers ,CD8 - Abstract
Background Generalized bullous fixed drug eruption (GBFDE), a particular form of fixed drug eruption (FDE), is characterized by widespread blisters and erosions and can be confused with Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Objective We sought to analyze specific features of GBFDE and differentiate it from SJS/TEN. Methods We retrospectively studied patients with GBFDE and SJS/TEN during a period of 10 years. GBFDE was defined as typical FDE lesions with blisters involving at least 10% body surface area on at least 3 of 6 different anatomic sites. Clinical presentations; histopathological features; immunohistochemical patterns of cluster-of-differentiation (CD)3, CD4, CD8, CD56, Fas, Fas ligand, granzyme B, perforin, granulysin, and forkhead box P3 (Foxp3); and serum granulysin levels were compared. Results Twenty-three cases of GBFDE were collected. Patients with GBFDE had shorter latent periods, less mucosal involvement, more eosinophil infiltration, and dermal melanophages. Lesional infiltrates in GBFDE had more dermal CD4 + cells including Foxp3 + regulatory T cells, fewer intraepidermal CD56 + cells, and fewer intraepidermal granulysin + cells. The serum level of granulysin in GBFDE was also significantly lower than in SJS/TEN. Limitations The number of cases in this study is small. Conclusion GBFDE is a distinct disease distinguishable from SJS/TEN by particular features such as granulysin, CD56, and Foxp3 expressions.
- Published
- 2014